New research published in The American Journal of Medicine shows that renin-angiotensin system-modifying antihypertensive drugs can reduce the risk of cardiovascular disease in patients with lupus erythematosus. In this video, AJM Editor-in-Chief Joseph S. Alpert, MD explains “Renin-Angiotensin System-Modifying Antihypertensive Drugs Can Reduce the Risk of Cardiovascular Complications in Lupus: A Retrospective Cohort” by Hurst et al. You can read this article in the March 2023 issue of AJM, available on our website amjmed.com.
Can RAS-Modifying Drugs Reduce CVD Risk in Lupus Patients? (video)
Latest Posts
Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man
A 54-year-old man of Afro-Caribbean ancestry presented with a 2-month history of nonproductive cough, 10-day history of constant subjective fevers, and a 1-day history...
Flu Vaccination to Prevent Cardiovascular Mortality (video)
"Influenza can cause a significant burden on patients with coronary artery disease," write Barbetta et al in The American Journal of Medicine. For this...
Varicella Zoster Virus-Induced Complete Heart Block
Complete heart block is usually caused by chronic myocardial ischemia and fibrosis but can also be induced by bacterial and viral infections. The varicella...
Teaching Anti-Racism in the Clinical Environment
"Teaching Anti-Racism in the Clinical Environment: The Five-Minute Moment for Racial Justice in Healthcare" was originally published in the April 2023 issue of The...
The ‘Invisible Hand’ Doesn’t Work for Prescription Drugs
Pharmaceutical innovation has been responsible for many “miracles of modern medicine.” Reliance on the “invisible hand” of Adam Smith to allocate resources in the...
New Coronary Heart Disease Risk Factors
"New Coronary Heart Disease Risk Factors" by AJM Editor-in Chief Joseph S. Alpert, MD was originally published in the April 2023 issue of The...
Cardiac Risk Related to Noncardiac & Nonsurgical Activities
"Assessment of Cardiovascular Risk for Noncardiac and Nonsurgical Activities" was originally published in the April 2023 issue of The American Journal of Medicine.
Cardiovascular risk...
